MireyaPaulinaVelasquezMD
Pediatric Hematology & Oncology • Memphis, TNClinical Postdoc Fellow, Pediatric Hematology & Oncology, Baylor College of Medicine
Dr. Velasquez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
262 Danny Thomas Pl MS 310
Memphis, TN 38105Phone+1 901-595-6528
Education & Training
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2011 - 2014- Baylor College of Medicine (Houston)Residency, Pediatrics, 2008 - 2011
Universidiad Francisco Marroquin Faculty of MedicineClass of 2006
Certifications & Licensure
TN State Medical License 2018 - 2026
TX State Medical License 2014 - 2026
UT State Medical License 2011 - 2012- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 126 citationsRedirecting T cells to hematological malignancies with bispecific antibodiesMireya Paulina Velasquez, Challice L. Bonifant, Stephen Gottschalk
Blood. 2018-01-04 - 142 citationsDeleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity.Brooke Prinzing, Caitlin C. Zebley, Christopher T. Petersen, Yiping Fan, Alejandro Allo Anido
Science Translational Medicine. 2021-11-17 - 64 citationsCD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid LeukemiaChallice L. Bonifant, Arpad Szoor, David Torres, Nicholos Joseph, Mireya Paulina Velasquez
Molecular Therapy. 2016-09-01
Abstracts/Posters
- Transgenic Expression of IL15 in CD123-Specific BiTE-Secreting Engager T-Cells Results in Improved Anti-AML ActivityMireya Paulina Velasquez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Inducible MyD88 Signaling Enhances the Anti-AML Activity of BiTE-Secreting ENG T-CellsMireya Paulina Velasquez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Engineering Naturally Occurring CD7 Negative Cells for the Immunotherapy of CD7 Positive LeukemiaMireya Paulina Velasquez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
